Pulmonary Hypertension Awareness Month

December 3, 2018

Actelion, the global leader in the treatment of pulmonary arterial hypertension (PAH), and newest member of the Johnson & Johnson family of companies, celebrated its 20 plus year heritage of innovation in this field. As part of Pulmonary Hypertension (PH) Awareness Month, the dinner was held to celebrate Actelion’s truly ground-breaking treatments which have enabled over 70,000 people affected by PH to lead longer, active lives.


The event was hosted by Victoria Tanner, Partner at C-Matrix and President of the Australian Swiss Chamber of Commerce. Speakers included Jane Griffiths, Global Head of Actelion, Christa Markwalder, National Councillor and President of the Swiss Parliamentary Association of Australia and New Zealand, and Richard Brook, President and CEO, EMEA and Latin America, Cochlear Ltd. Jane Griffiths and her team, outlined how Actelion achieved its international success “From Australia to Switzerland”.


1 2 3 17